FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2957527574> ?p ?o ?g. }

• W2957527574 endingPage "20" @default.
• W2957527574 startingPage "16" @default.
• W2957527574 abstract "Recently, intermediate and high-risk prostate cancer patients have been treated in a multicenter phase II trial with extremely hypofractionated prostate radiotherapy (hypo-FLAME trial). The purpose of the current study was to investigate whether a 1.5 T magnetic resonance imaging guided linear accelerator (MRI-linac) could achieve complex dose distributions of a quality similar to conventional linac state-of-the-art prostate treatments.The clinically delivered treatment plans of 20 hypo-FLAME patients (volumetric modulated arc therapy, 10 MV, 5 mm leaf width) were included. Prescribed dose to the prostate was 5 × 7 Gy, with a focal tumor boost up to 5 × 10 Gy. MRI-linac treatment plans (intensity modulated radiotherapy, 7 MV, 7 mm leaf width, fixed collimator angle and 1.5 T magnetic field) were calculated. Dose distributions were compared.In both conventional and MRI-linac treatment plans, the V35Gy to the whole prostate was >99% in all patients. Mean dose to the gross tumor volume was 45 Gy for conventional and 44 Gy for MRI-linac plans, respectively. Organ at risk doses were met in the majority of plans, except for a rectal V35Gy constraint, which was exceeded in one patient, by 1 cc, for both modalities. The bladder V32Gy and V28Gy constraints were exceeded in two and one patient respectively, for both modalities.Planning of stereotactic radiotherapy with focal ablative boosting in prostate cancer on a high field MRI-linac is feasible with the current MRI-linac properties, without deterioration of plan quality compared to conventional treatments." @default.
• W2957527574 created "2019-07-23" @default.
• W2957527574 creator A5002901679 @default.
• W2957527574 creator A5006895484 @default.
• W2957527574 creator A5006933833 @default.
• W2957527574 creator A5016754892 @default.
• W2957527574 creator A5016818579 @default.
• W2957527574 creator A5026097028 @default.
• W2957527574 creator A5048061452 @default.
• W2957527574 creator A5050756461 @default.
• W2957527574 creator A5054431032 @default.
• W2957527574 creator A5072340345 @default.
• W2957527574 creator A5074419565 @default.
• W2957527574 creator A5076098915 @default.
• W2957527574 creator A5089967041 @default.
• W2957527574 date "2019-07-01" @default.
• W2957527574 modified "2023-10-07" @default.
• W2957527574 title "Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator" @default.
• W2957527574 cites W1978933402 @default.
• W2957527574 cites W2018079976 @default.
• W2957527574 cites W2023635060 @default.
• W2957527574 cites W2040357326 @default.
• W2957527574 cites W2040876462 @default.
• W2957527574 cites W2076170353 @default.
• W2957527574 cites W2083073611 @default.
• W2957527574 cites W2104850484 @default.
• W2957527574 cites W2110881680 @default.
• W2957527574 cites W2113472764 @default.
• W2957527574 cites W2124539070 @default.
• W2957527574 cites W2125048685 @default.
• W2957527574 cites W2160817777 @default.
• W2957527574 cites W2163516846 @default.
• W2957527574 cites W2167221711 @default.
• W2957527574 cites W2186933218 @default.
• W2957527574 cites W2203526994 @default.
• W2957527574 cites W2214838716 @default.
• W2957527574 cites W2339279535 @default.
• W2957527574 cites W2339647035 @default.
• W2957527574 cites W2346938452 @default.
• W2957527574 cites W2466944239 @default.
• W2957527574 cites W2523396458 @default.
• W2957527574 cites W2560303100 @default.
• W2957527574 cites W2604506868 @default.
• W2957527574 cites W2619649543 @default.
• W2957527574 cites W2739527645 @default.
• W2957527574 cites W2751821782 @default.
• W2957527574 cites W2761071017 @default.
• W2957527574 cites W2765703828 @default.
• W2957527574 cites W2767171201 @default.
• W2957527574 cites W2768510334 @default.
• W2957527574 cites W2783618800 @default.
• W2957527574 cites W2790201823 @default.
• W2957527574 cites W2793336333 @default.
• W2957527574 cites W2884680344 @default.
• W2957527574 cites W2887837678 @default.
• W2957527574 cites W2913811067 @default.
• W2957527574 cites W2914880936 @default.
• W2957527574 cites W2915897154 @default.
• W2957527574 cites W2930910485 @default.
• W2957527574 cites W2940561474 @default.
• W2957527574 cites W2941165817 @default.
• W2957527574 cites W2952903287 @default.
• W2957527574 doi "https://doi.org/10.1016/j.phro.2019.07.002" @default.
• W2957527574 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7807729" @default.
• W2957527574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33458271" @default.
• W2957527574 hasPublicationYear "2019" @default.
• W2957527574 type Work @default.
• W2957527574 sameAs 2957527574 @default.
• W2957527574 citedByCount "11" @default.
• W2957527574 countsByYear W29575275742019 @default.
• W2957527574 countsByYear W29575275742020 @default.
• W2957527574 countsByYear W29575275742021 @default.
• W2957527574 countsByYear W29575275742022 @default.
• W2957527574 countsByYear W29575275742023 @default.
• W2957527574 crossrefType "journal-article" @default.
• W2957527574 hasAuthorship W2957527574A5002901679 @default.
• W2957527574 hasAuthorship W2957527574A5006895484 @default.
• W2957527574 hasAuthorship W2957527574A5006933833 @default.
• W2957527574 hasAuthorship W2957527574A5016754892 @default.
• W2957527574 hasAuthorship W2957527574A5016818579 @default.
• W2957527574 hasAuthorship W2957527574A5026097028 @default.
• W2957527574 hasAuthorship W2957527574A5048061452 @default.
• W2957527574 hasAuthorship W2957527574A5050756461 @default.
• W2957527574 hasAuthorship W2957527574A5054431032 @default.
• W2957527574 hasAuthorship W2957527574A5072340345 @default.
• W2957527574 hasAuthorship W2957527574A5074419565 @default.
• W2957527574 hasAuthorship W2957527574A5076098915 @default.
• W2957527574 hasAuthorship W2957527574A5089967041 @default.
• W2957527574 hasBestOaLocation W29575275741 @default.
• W2957527574 hasConcept C120665830 @default.
• W2957527574 hasConcept C121332964 @default.
• W2957527574 hasConcept C121608353 @default.
• W2957527574 hasConcept C126322002 @default.
• W2957527574 hasConcept C126838900 @default.
• W2957527574 hasConcept C143409427 @default.
• W2957527574 hasConcept C168834538 @default.
• W2957527574 hasConcept C180048950 @default.
• W2957527574 hasConcept C201645570 @default.

• next